Nationally Notifiable Infectious Diseases and Conditions, United States: Annual Tables

TABLE 2d. Annual reported cases of notifiable diseases, by region and reporting area, United States and U.S. Territories, excluding Non-U.S. Residents*, 2019
Data from some jurisdictions may be incomplete due to the coronavirus disease 2019 (COVID-19) pandemic. Please see Note #9 at the bottom of the table.
Reporting Area Brucellosis Campylobacteriosis Candida auris, clinical § Carbapenemase-producing carbapenem-resistant Enterobacteriaceae Chancroid Chlamydia trachomatis infection
U.S. Residents, excluding U.S. Territories 165 71,509 175 1,483 8 1,808,703
New England 2 3,493 15 3 61,914
Connecticut 734 15,290
Maine 191 3,989
Massachusetts 2 1,732 3 31,622
New Hampshire 302 3,577
Rhode Island 355 15 5,718
Vermont 179 1,718
Middle Atlantic 16 10,132 61 223,907
New Jersey 1 1,996 37,591
New York (excluding New York City) 3 2,488 48,696
New York City 5 2,908 61 75,926
Pennsylvania 7 2,740 61,694
East North Central 8 9,331 170 462 261,019
Illinois 5 2,541 170 81,012
Indiana 1 1,065 271 35,430
Michigan 1 1,651 162 50,104
Ohio 2,442 65,393
Wisconsin 1 1,632 29 29,080
West North Central 9 6,593 8 107,934
Iowa 2 1,391 16,044
Kansas 790 15,286
Minnesota 4 1,492 24,470
Missouri 1 1,348 34,416
Nebraska 2 811 9,291
North Dakota 237 3,880
South Dakota 524 8 4,547
South Atlantic 27 11,754 5 730 1 391,469
Delaware 5 208 5,864
District of Columbia 1 133 9,327
Florida 8 4,525 N N 110,794
Georgia 5 1,380 1 262 67,720
Maryland 2 892 3 1 37,779
North Carolina 1 1,997 1 249 70,257
South Carolina 2 553 35,950
Virginia 3 1,641 219 48,169
West Virginia 425 5,609
East South Central 6 3,403 71 2 118,531
Alabama 4 750 N N 31,228
Kentucky 1,127 2 20,911
Mississippi 601 71 25,303
Tennessee 2 925 41,089
West South Central 54 7,959 205,920
Arkansas 3 719 17,196
Louisiana 5 871 36,131
Oklahoma 2 1,191 23,518
Texas 44 5,178 129,075
Mountain 10 5,525 100 1 129,869
Arizona 2 1,615 77 1 43,058
Colorado 2 1,245 29,821
Idaho 2 551 6,863
Montana 372 4,753
Nevada 2 237 9 17,827
New Mexico 1 688 14,283
Utah 1 581 12 11,075
Wyoming 236 2 2,189
Pacific 33 13,319 36 1 308,140
Alaska 1 129 6,254
California 23 9,790 4 1 236,719
Hawaii 6 401 2 8,093
Oregon 1,020 19,279
Washington 3 1,979 30 37,795
U.S. Territories 1 46 3 49 6,918
American Samoa 81
Commonwealth of Northern Mariana Islands 249
Guam 1 13 3 1,234
Puerto Rico 33 49 4,817
U.S. Virgin Islands 537
  • —: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • U: Unavailable — The data are unavailable.
  • * The 2019 annual tables exclude cases of nationally notifiable conditions and diseases among non-U.S. residents. As a result, data in Table 2 does not include a "Non-U.S. Resident" or "Total" row, that would have been included in the table had the data been stratified into the following four categories, based upon the "country of usual residence" (COUR) algorithm: U.S. Residents, excluding U.S. Territories; U.S. Territories; Non-US. Residents; and Total.Table 2 for the 2019 annual tables only includes the first two of these stratification categories.
  • † To calculate rates, use the populations provided in Table 8. Note that calculation of rates for the following conditions use population subsets presented in Table 8: Zika virus infection, congenital; Zika virus disease, congenital; Infant botulism; Congenital rubella syndrome; Perinatal Hepatitis B infection, Perinatal Hepatitis C infection, Haemophilus influenzae, invasive disease and Invasive pneumococcal disease, and Influenza associated pediatric mortality; see Table 8 (population reference table). Also see notes 3 and 7.
  • § Candida auris colonization/screening cases are not included in this table. These data are available on the Mycotic Diseases Branch's Tracking Candida auris page (https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html)